36 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Pinto, Medical Oncologist in Stanford, CA?
Dr. Harlan Pinto, MD is a Medical Oncologist, who primarily practices in Stanford, CA with 1 additional practice location. He has been practicing for over 36 years and is board certified by the American Board of Internal Medicine. Dr. Pinto graduated from Yale University School of Medicine and completed his residency at Massachusetts General Hospital. Dr. Pinto is fluent in English and Spanish, and is currently seeing new patients. Dr. Pinto’s practice accepts Medicaid, Medicare, UnitedHealthcare, Cigna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Pinto’s office at (650) 498-6000.
What are Areas of Expertise for Dr. Pinto?
Dr. Harlan Pinto, MD is a highly-rated, board-certified Medical Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Pinto empowers patients to confidently navigate their health journey, specializing in Clinical Trials, Head & Neck Cancer, or comprehensive wellness support. Serving the Stanford/CA community, Dr. Pinto is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Pinto go to medical school and complete their residency?
Fellowship: Stanford University School of Medicine,Stanford, Ca, United States
Residency: Massachusetts General Hospital
Medical School: Yale University School of Medicine
Is Dr. Pinto board certified in Medical Oncologist?
Yes, Dr. Harlan Pinto, MD is board certified by the American Board of Internal Medicine since 1991, American Board of Internal Medicine since 1986
What languages does Dr. Pinto speak?
Dr. Pinto and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does Dr. Pinto treat?
As a Medical Oncologist, Dr. Pinto diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Pinto. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Cancer Chemotherapy
- Cancer Immunotherapy
- Chemo treatment
- Oncology chemotherapy
- Cancer drug therapy
- Oncology immunotherapy
- Immune therapy for cancer
ICD-10 Codes:
- Z5111: Encounter for antineoplastic chemotherapy
- Z5112: Encounter for antineoplastic immunotherapy
Also known as:
- Cancer Follow-up Exam
- Secondary Cancer (Other Specified Sites)
- Secondary Bone Cancer
- Cancer
- Bone Cancer
- Post-cancer treatment checkup
- Malignancy surveillance
- Oncology follow-up
- Metastatic cancer
- Cancer spread to other organs
- Cancer metastases
- Metastatic bone cancer
- Cancer spread to bone
- Bone metastases
ICD-10 Codes:
- Z08: Encounter for follow-up examination after completed treatment for malignant neoplasm
- C7989: Secondary malignant neoplasm of other specified sites
- C7951: Secondary malignant neoplasm of bone
Also known as:
- Throat Cancer
- Oral Cancer
- Oropharyngeal Cancer
- Malignant Neoplasm of Oropharynx
- Pharyngeal Cancer
- Nasopharyngeal Cancer
- Malignant Neoplasm of Nasopharynx
- Tonsil Cancer
- Malignant Neoplasm of Tonsil
- Laryngeal Cancer
- Voice Box Cancer
- Malignant Laryngeal Tumor
ICD-10 Codes:
- C109: Malignant neoplasm of oropharynx, unspecified
- C119: Malignant neoplasm of nasopharynx, unspecified
- C099: Malignant neoplasm of tonsil, unspecified
- C329: Malignant neoplasm of larynx, unspecified
Also known as:
- Oral Cancer
- Mouth Cancer
- Tongue Cancer
- Oral Cavity Cancer
- Tongue Carcinoma
- Malignant Neoplasm of Tongue
ICD-10 Codes:
- C01: Malignant neoplasm of base of tongue
- C029: Malignant neoplasm of tongue, unspecified
Also known as:
- Nasal Cancer
- Sinus Cancer
- Head and Neck Cancer
- Nasal Cavity Cancer
- Nose Cancer
- Malignant Nasal Tumor
- Maxillary sinus cancer
- Nasal sinus cancer
- Malignant neoplasm of maxillary sinus
- Head Cancer
- Neck Cancer
- Facial Cancer
- Malignant Head and Neck Tumor
ICD-10 Codes:
- C300: Malignant neoplasm of nasal cavity
- C310: Malignant neoplasm of maxillary sinus
- C760: Malignant neoplasm of head, face and neck
Also known as:
- Secondary Cancer in Head and Neck Lymph Nodes
- Cancer
- Metastatic Cancer to Neck Lymph Nodes
- Head and Neck Lymph Node Cancer Spread
- Lymph Node Metastasis in Neck
ICD-10 Codes:
- C770: Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
Also known as:
- Squamous Cell Skin Cancer of the Scalp or Neck
- Squamous Cell Skin Cancer of the Face
- Skin Cancer
- Skin Cancer Treatment (PDQ®)
- Squamous Cell Carcinoma of Scalp
- Squamous Cell Carcinoma of Neck
- Scalp SCC
- Neck SCC
- Squamous Cell Carcinoma of Face
- Facial SCC
- Cutaneous Squamous Cell Carcinoma of Face
- Face Skin Malignancy
ICD-10 Codes:
- C4442: Squamous cell carcinoma of skin of scalp and neck
- C44320: Squamous cell carcinoma of skin of unspecified parts of face
- C44329: Squamous cell carcinoma of skin of other parts of face
Also known as:
- Thyroid Cancer
- Thyroid Carcinoma
- Malignant Thyroid Nodule
- Thyroid Gland Cancer
ICD-10 Codes:
- C73: Malignant neoplasm of thyroid gland
Also known as:
- Oropharyngeal Dysphagia
- Swallowing Disorder
- Difficulty Swallowing in Throat
- Trouble Starting to Swallow
- Throat Swallowing Problems
ICD-10 Codes:
- R1312: Dysphagia, oropharyngeal phase
Which procedures does Dr. Pinto perform as a Medical Oncologist?
As a Medical Oncologist, procedures performed by a Dr. Harlan Pinto may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
For detailed information, please contact Dr. Pinto's office.
Does Dr. Pinto accept my insurance?
Dr. Pinto accepts most major insurance plans. Important: Please call our office at (650) 498-6000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Pinto accept in Stanford, CA?
Dr. Pinto in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Advantage
All Other Third Party
Blue Shield of California
Care N' Care
Central California Alliance for Health
CVS Health (formerly Aetna)
Medicaid
Medicare
Other Provider Networks
UnitedHealthcare
View All Insurances
Where is Dr. Pinto's office located?
Recognitions
Publications
INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX
HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N, 2011
INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010
In vivo H-1 magnetic resonce spectroscopy of lactate in patients with Stage IV head
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008
Excellent local control with stereotactic radiotherapy boost after exterl beam radiotherapy
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008
Improved survival of patients with human papillomavirus-positive head
JOURL OF THE TIOL CANCER INSTITUTE, 2008
Evaluation of patterns of failure
HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N, 2007
Clinical role of F-18-FDG PET
JOURL OF NUCLEAR MEDICINE, 2007
Plasma osteopontin is an independent prognostic marker for head and neck cancers
JOURL OF CLINICAL ONCOLOGY, 2006
Advanced-staged tonsillar squamous carcinoma
HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N, 2006
Phase II double-blind r
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004
Improved local control with stereotactic radiosurgical boost
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003
Comparison of the comet assay
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003
Estimating D repair by sequential evaluation of head
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002
In vivo H-1 MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen
AMERICAN JOURL OF NEURORADIOLOGY, 2000
D damage measured by the comet assay in head and neck cancer patients treated with tirapazamine.
Neoplasia, 1999
Stereotactic radiosurgical boost following radiotherapy in primary sopharyngeal carcinoma
Tate, D. J., Adler, J. R., Chang, S. D., Marquez, S., Eulau, S. M., Fe, 1999
Tissue oxygen distribution in head and neck cancer patients
HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N, 1999
Magement of the clinically positive neck in organ preservation for advanced head and neck cancer
AMERICAN JOURL OF SURGERY, 1998
Adjuvant and neoadjuvant treatment of head and neck cancers: The next chapter
SEMIRS IN ONCOLOGY, 1995
Head and neck cancers.
Macdold JS, Haller DG, Mayer RJ (eds), Manual of Oncologic Therapeutic, 1995
INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND, 2011
INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010
In vivo H-1 magnetic resonance spectroscopy of lactate in patients with Stage IV head
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008
Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008
Improved survival of patients with human papillomavirus-positive head
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008
Evaluation of patterns of failure
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND, 2007
Clinical role of F-18-FDG PET
JOURNAL OF NUCLEAR MEDICINE, 2007
Plasma osteopontin is an independent prognostic marker for head and neck cancers
JOURNAL OF CLINICAL ONCOLOGY, 2006
Advanced-staged tonsillar squamous carcinoma
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND, 2006
Mature results from a randomized phase II trial of cisplatin plus 5
CANCER, 2006
Positron-emission tomography for surveillance of head and neck cancer
LARYNGOSCOPE, 2005
Long-term results of 100 consecutive comprehensive neck dissections
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004
Phase II double-blind r
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004
Improved local control with stereotactic radiosurgical boost
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003
Comparison of the comet assay
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003
Identification of osteopontin as a prognostic plasma marker for head
CLINICAL CANCER RESEARCH, 2003
Estimating DNA repair by sequential evaluation of head
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002
In vivo H-1 MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen
AMERICAN JOURNAL OF NEURORADIOLOGY, 2000
DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine.
Neoplasia, 1999
Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma
Tate, D. J., Adler, J. R., Chang, S. D., Marquez, S., Eulau, S. M., Fe, 1999
Tissue oxygen distribution in head and neck cancer patients
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND, 1999
Pretreatment and midtreatment measurement of oxygen tension levels in head and neck cancers
LARYNGOSCOPE, 1998
Management of the clinically positive neck in organ preservation for advanced head and neck cancer
AMERICAN JOURNAL OF SURGERY, 1998
Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer
Newman, J. P., Terris, D. J., Pinto, H. A., Fee, W. E., Goode, R. L., , 1997
Adjuvant and neoadjuvant treatment of head and neck cancers: The next chapter
SEMINARS IN ONCOLOGY, 1995
Distant metastases from head and neck squamous cancer: the role of adjuvant chemotherapy.
Cancer treatment and research, 1995
Head and neck cancers.
Macdonald JS, Haller DG, Mayer RJ (eds), Manual of Oncologic Therapeut, 1995
Head and neck cancer - combined modality therapy and chemotherapy.
: Brian MC and Carbone PP (eds), Current Therapy in Hematology-Oncolog
CHEMOTHERAPY FOR RECURRENT AND METASTATIC HEAD AND NECK-CANCER
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1991
What is Dr. Pinto's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Pinto's National Provider Identifier (NPI) number is 1194813956.
What common questions do patients ask about Dr. Pinto?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Pinto
What is Dr. Harlan Pinto's specialty?
Dr. Pinto is a Medical Oncologist near Stanford, CA. An internist specializing in the diagnosis and treatment of various cancers and both benign and malignant tumors. This specialist determines and administers therapy for malignancies and collaborates with surgeons and radiation oncologists on additional cancer treatment options. Contact Dr. Pinto to book an appointment today.
Is this Dr. Harlan Pinto affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Pinto is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Medical Oncologist?
Explore Medical Oncologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Harlan Pinto accepting new patients in Stanford, CA?
Yes, Dr. Harlan Pinto is accepting new patients at this time.
Does Dr. Harlan Pinto offer online booking?
Please contact Dr. Pinto's office at (650) 498-6000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Harlan Pinto?
Please contact Dr. Pinto's office at (650) 498-6000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Harlan Pinto have?
Dr. Harlan Pinto is certified by the American Board of Internal Medicine.
Other Medical Oncologist Near Stanford, CA
Medical Oncologist
Accepting patientsMedical Oncologist
Accepting patientsMedical Oncologist
Accepting patients